| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18541797 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 109 journal articles in the PubMed database | Email to a friend | | |
| Locascio JJ, Fukumoto H, Yap L, et al.
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. [Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Arch Neurol 2008 Jun; 65(6):776-85.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Graff-Radford NR, Crook JE, Lucas J, et al.
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Arch Neurol 2007 Mar; 64(3):354-62.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Blasko I, Jellinger K, Kemmler G, et al.
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. [JOURNAL ARTICLE]
Neurobiol Aging 2006 Oct 19.
Abstract | Full Citation | Find Related Articles | | Mehta PD, Pirttilä T, Mehta SP, et al.
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. [Journal Article, Multicenter Study]
Arch Neurol 2000 Jan; 57(1):100-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lopez OL, Wisniewski SR, Becker JT, et al.
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. [Journal Article]
Arch Neurol 1999 Oct; 56(10):1266-72.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Galasko D, Chang L, Motter R, et al.
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. [Clinical Trial, Controlled Clinical Trial, Journal Article, Multicenter Study]
Arch Neurol 1998 Jul; 55(7):937-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gurol ME, Irizarry MC, Smith EE, et al.
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. [Journal Article]
Neurology 2006 Jan 10; 66(1):23-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schupf N, Patel B, Pang D, et al.
Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Arch Neurol 2007 Jul; 64(7):1007-13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fukumoto H, Tennis M, Locascio JJ, et al.
Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. [Journal Article]
Arch Neurol 2003 Jul; 60(7):958-64.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
